Reuters logo
BRIEF-Takeda gets FDA approval for ALUNBRIG 180 mg tablets
October 3, 2017 / 12:25 PM / 17 days ago

BRIEF-Takeda gets FDA approval for ALUNBRIG 180 mg tablets

Oct 3 (Reuters) - Takeda Pharmaceutical Co Ltd

* Takeda announces FDA approval of ALUNBRIG (brigatinib) 180 mg tablets

* Takeda Pharmaceutical Co Ltd - 180 mg tablets and previously approved 90 mg tablets will be available later this year Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below